For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...

The FDA Fast Track and Accelerated Approval pathways have major implications for the wider healthcare landscape beyond drug ...

Milestone Pharmaceuticals (MIST) has released an update. Milestone Pharmaceuticals is gearing up for the potential FDA approval of its CARDAMYST nasal spray for PSVT, with a decision expected by March ...

Joint efforts promise innovative drug solutions and enhanced offerings while enabling comprehensive development of active ...

The intersection of sports marketing and the pharmaceutical industry offers a dynamic space where brands can leverage ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Transpire Bio expands headquarters in Weston, adding 6,600 square feet. New executives join, including Stuart Loesch and Todd ...

de-risking early-stage development, or leveraging the potential of AI in its work. DSI provides regulatory, technical, and ...

Shyra Gardai, chief scientific officer at the molecular glue start-up EpiBiologics, says Big Pharma’s recent interest in glue ...

However, the biotech and pharmaceutical companies that develop these therapies do so at great expense. High drug development ...